
Tariff-related Litigation Update
Explore the latest IEEPA tariff developments and legal challenges, including executive orders on fentanyl tariffs and reciprocal duties affecting global MedTech trade.
Explore the latest IEEPA tariff developments and legal challenges, including executive orders on fentanyl tariffs and reciprocal duties affecting global MedTech trade.
Scott Whitaker’s Senate testimony, drug pricing EO, and updates on key RFIs drive this week’s momentum for MedTech advocacy.
The U.S. Supreme Court is reviewing Braidwood Management v. Becerra, a high-stakes case challenging the authority of the U.S. Preventive Services Task Force (USPSTF) under the Affordable Care Act. At…
Domestic manufacturing EO, federal reforms, and critical RFIs signal changes for MedTech—member input still welcome.
No FDA overhaul, new federal procurement EOs, and a major court case could shift preventive care coverage requirements.
FDA reorg, port fees, and policy shifts top this week’s update—plus, help shape future AdvaMed rapid response priorities.
Although the individual claims may differ, a review of recent products liability claims levied against industries targeted by the plaintiffs trial bar reveals common threads. For example, the drivers of…
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.